{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T21:43:02Z","timestamp":1777758182287,"version":"3.51.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of mortality and health burden worldwide. We aimed to assess ASCVD epidemiology, 10-year risk, and cardiometabolic care using nationally representative data in Iran. Using the 2021 Iran STEPS study, a cross-sectional analysis was conducted to evaluate ASCVD (self-reported myocardial infarction, angina, revascularization, or stroke) prevalence and annual event rate. The 2013 AHA\/ACC pooled cohort equations estimated 10-year ASCVD risk in 10,298 participants aged 40\u201375 without ASCVD. Cardiometabolic care for hypertension, diabetes mellitus (DM), and hypercholesterolemia was assessed, along with statin use and cardiovascular health (CVH) metrics. Among 27,822 participants, representing 57.5 million adults, ASCVD prevalence was 7.4%. Among those without ASCVD, 19.1% had an intermediate and 5.4% had a high ASCVD risk. In the ASCVD group, hypertension and DM affected 77.0% and 34.7%, yet only 12.5% and 14.3% of the entire ASCVD group had them controlled, respectively. In adults without ASCVD, 2.9\u20135.3% of the entire risk groups achieved hypertension targets, 2.5\u201316.8% achieved glycemic targets, and 7.7\u201316.7% achieved lipid goals, despite condition prevalence spanning 47.4\u201394.4% for hypertension, 7.2\u201359.3% for DM, and 33.5\u201348.7% for hypercholesterolemia. CVH metrics were also unfavorable. The study revealed a high ASCVD burden and future risks with gaps in coverage, treatment, and control.<\/jats:p>","DOI":"10.1038\/s41598-026-45344-0","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:33:41Z","timestamp":1774589621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and cardiometabolic care in adults with ASCVD and high 10-year ASCVD risk: 2021 WHO STEPS study in Iran"],"prefix":"10.1038","volume":"16","author":[{"given":"Hossein","family":"Farrokhpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Nasserinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naser","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Golestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Keykhaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Azadnajafabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arya","family":"Aminorroaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Naderian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazila","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Djalalinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosef","family":"Farzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Mahdi","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erfan","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Abdolhamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moein","family":"Yoosefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameneh","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Haghshenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Taghi","family":"Majnoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"25","key":"45344_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V. & Roth, G. A. The global burden of cardiovascular diseases and risk: A compass for future health. J. Am. Coll. Cardiol. 80(25), 2361\u20132371. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.005 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"45344_CR2","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"A Mensah George","year":"2023","unstructured":"Mensah George, A. et al. Global burden of cardiovascular diseases and risks, 1990\u20132022. J. Am. Coll. Cardiol. 82(25), 2350\u20132473. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.007 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"45344_CR3","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jacc.2023.11.003","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah, G. A., Fuster, V. & Roth, G. A. A heart-healthy and stroke-free world. J. Am. Coll. Cardiol. 82(25), 2343\u20132349. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.003 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10335","key":"45344_CR4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)02751-3","volume":"399","author":"F Farzadfar","year":"2022","unstructured":"Farzadfar, F. et al. Health system performance in Iran: A systematic analysis for the global burden of disease study 2019. Lancet 399(10335), 1625\u20131645. https:\/\/doi.org\/10.1016\/S0140-6736(21)02751-3 (2022).","journal-title":"Lancet"},{"issue":"10184","key":"45344_CR5","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(18)33197-0","volume":"393","author":"G Danaei","year":"2019","unstructured":"Danaei, G. et al. Iran in transition. Lancet 393(10184), 1984\u20132005. https:\/\/doi.org\/10.1016\/S0140-6736(18)33197-0 (2019).","journal-title":"Lancet"},{"issue":"2","key":"45344_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031427","volume":"7","author":"D Khalili","year":"2012","unstructured":"Khalili, D. et al. Evaluation of cause of deaths\u2019 validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS ONE 7(2), e31427. https:\/\/doi.org\/10.1371\/journal.pone.0031427 (2012).","journal-title":"PLoS ONE"},{"key":"45344_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-020-00669-z","author":"A Aminorroaya","year":"2020","unstructured":"Aminorroaya, A. et al. Burden of non-communicable diseases in Iran: Past, present, and future. J. Diabetes Metab. Disord. https:\/\/doi.org\/10.1007\/s40200-020-00669-z (2020).","journal-title":"J. Diabetes Metab. Disord."},{"key":"45344_CR8","unstructured":"Institute for Health Metrics and Evaluation (IHME) S, WA: IHME, University of Washington. GBD Compare Data Visualization 2024 [Available from: https:\/\/vizhub.healthdata.org\/gbd-compare\/."},{"key":"45344_CR9","doi-asserted-by":"publisher","first-page":"e9028","DOI":"10.1161\/jaha.123.030165","volume":"2023","author":"A Aminorroaya","year":"2024","unstructured":"Aminorroaya, A. et al. The burden of ischemic heart disease and its attributable risk factors in North Africa and Middle East, 1990\u20132019: Results from the GBD study 2019. J. Am. Heart Assoc. 2023, e9028. https:\/\/doi.org\/10.1161\/jaha.123.030165 (2024).","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"45344_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/eurjpc\/zwab066","volume":"29","author":"A Aminorroaya","year":"2022","unstructured":"Aminorroaya, A. et al. Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: A systematic analysis for the global burden of disease study 2017. Eur. J. Prev. Cardiol. 29(2), 371\u2013379. https:\/\/doi.org\/10.1093\/eurjpc\/zwab066 (2022).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"10440","key":"45344_CR11","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"AE Schumacher","year":"2024","unstructured":"Schumacher, A. E. et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: A comprehensive demographic analysis for the global burden of disease study 2021. Lancet 403(10440), 1989\u20132056. https:\/\/doi.org\/10.1016\/S0140-6736(24)00476-8 (2024).","journal-title":"Lancet"},{"issue":"11","key":"45344_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s0195-668x(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy, R. M. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 24(11), 987\u20131003. https:\/\/doi.org\/10.1016\/s0195-668x(03)00114-3 (2003).","journal-title":"Eur. Heart J."},{"issue":"25_suppl_2","key":"45344_CR13","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff","year":"2014","unstructured":"Goff, D. C. et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk. Circulation 129(25_suppl_2), S49\u2013S73. https:\/\/doi.org\/10.1161\/01.cir.0000437741.48606.98 (2014).","journal-title":"Circulation"},{"issue":"6","key":"45344_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino, R. B. et al. General cardiovascular risk profile for use in primary care. Circulation 117(6), 743\u2013753. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.699579 (2008).","journal-title":"Circulation"},{"issue":"10","key":"45344_CR15","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1016\/S2214-109X(19)30318-3","volume":"7","author":"S Kaptoge","year":"2019","unstructured":"Kaptoge, S. et al. World health organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. Lancet. Glob. Health. 7(10), e1332\u2013e1345. https:\/\/doi.org\/10.1016\/S2214-109X(19)30318-3 (2019).","journal-title":"Lancet. Glob. Health."},{"key":"45344_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijcard.2015.03.067","volume":"184","author":"D Khalili","year":"2015","unstructured":"Khalili, D. et al. A new approach to test validity and clinical usefulness of the 2013 ACC\/AHA guideline on statin therapy: A population-based study. Int. J. Cardiol. 184, 587\u2013594. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.067 (2015).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"45344_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02686-1","volume":"19","author":"F Hadaegh","year":"2021","unstructured":"Hadaegh, F. et al. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study. J. Transl. Med. 19(1), 25. https:\/\/doi.org\/10.1186\/s12967-020-02686-1 (2021).","journal-title":"J. Transl. Med."},{"issue":"8","key":"45344_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290006","volume":"18","author":"H Ebrahimi","year":"2023","unstructured":"Ebrahimi, H. et al. Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys. PLoS ONE 18(8), e0290006. https:\/\/doi.org\/10.1371\/journal.pone.0290006 (2023).","journal-title":"PLoS ONE"},{"issue":"11","key":"45344_CR19","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1161\/cir.0000000000000677","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett, D. K. et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines. Circulation 140(11), e563\u2013e595. https:\/\/doi.org\/10.1161\/cir.0000000000000677 (2019).","journal-title":"Circulation"},{"issue":"9","key":"45344_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.34172\/aim.2022.99","volume":"25","author":"S Djalalinia","year":"2022","unstructured":"Djalalinia, S. et al. Protocol design for surveillance of risk factors of non-communicable diseases during the COVID-19 pandemic: An experience from Iran STEPS survey 2021. Arch. Iran. Med. 25(9), 634\u2013646. https:\/\/doi.org\/10.34172\/aim.2022.99 (2022).","journal-title":"Arch. Iran. Med."},{"issue":"1","key":"45344_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/m17-3011","volume":"169","author":"S Yadlowsky","year":"2018","unstructured":"Yadlowsky, S. et al. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann. Intern. Med. 169(1), 20\u201329. https:\/\/doi.org\/10.7326\/m17-3011 (2018).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"45344_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39433-7","volume":"13","author":"S Azadnajafabad","year":"2023","unstructured":"Azadnajafabad, S. et al. Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021. Sci. Rep. 13(1), 13528. https:\/\/doi.org\/10.1038\/s41598-023-39433-7 (2023).","journal-title":"Sci. Rep."},{"issue":"10304","key":"45344_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"B Zhou","year":"2021","unstructured":"Zhou, B. et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398(10304), 957\u2013980. https:\/\/doi.org\/10.1016\/S0140-6736(21)01330-1 (2021).","journal-title":"Lancet"},{"issue":"1","key":"45344_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42341-5","volume":"13","author":"J Khanali","year":"2023","unstructured":"Khanali, J. et al. Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from STEPs survey 2021. Sci. Rep. 13(1), 15499. https:\/\/doi.org\/10.1038\/s41598-023-42341-5 (2023).","journal-title":"Sci. Rep."},{"issue":"4","key":"45344_CR25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones, D. M. et al. Defining and setting national goals for cardiovascular health promotion and disease reduction. Circulation 121(4), 586\u2013613. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192703 (2010).","journal-title":"Circulation"},{"issue":"3","key":"45344_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102341","volume":"49","author":"L Alhuneafat","year":"2024","unstructured":"Alhuneafat, L. et al. Cardiovascular disease burden in the Middle East and North Africa region. Curr. Probl. Cardiol. 49(3), 102341. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102341 (2024).","journal-title":"Curr. Probl. Cardiol."},{"key":"45344_CR27","unstructured":"\u00dcner S BM, Erg\u00fcder T, editors. National Household Health Survey\u2014Prevalence of Noncommunicable Disease Risk Factors in Turkey, 2017 (STEPS) [Internet]. Ankara: World Health Organization Country Office in Turkey; (2018)."},{"key":"45344_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100634","volume":"17","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Trends in prevalence, risk factor control and medications in atherosclerotic cardiovascular disease among US adults, 1999\u20132018. Am. J. Prev. Cardiol. 17, 100634. https:\/\/doi.org\/10.1016\/j.ajpc.2024.100634 (2024).","journal-title":"Am. J. Prev. Cardiol."},{"issue":"2","key":"45344_CR29","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s40200-023-01186-5","volume":"22","author":"E Mohammadi","year":"2023","unstructured":"Mohammadi, E. et al. Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; A population-based STEPS 2016 small area spatial estimation model. J. Diabetes Metab. Disord. 22(2), 1095\u20131103. https:\/\/doi.org\/10.1007\/s40200-023-01186-5 (2023).","journal-title":"J. Diabetes Metab. Disord."},{"issue":"9866","key":"45344_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0140-6736(12)61851-0","volume":"381","author":"M Di Cesare","year":"2013","unstructured":"Di Cesare, M. et al. Inequalities in non-communicable diseases and effective responses. Lancet 381(9866), 585\u2013597. https:\/\/doi.org\/10.1016\/S0140-6736(12)61851-0 (2013).","journal-title":"Lancet"},{"issue":"23","key":"45344_CR31","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jacc.2008.08.049","volume":"52","author":"R Joshi","year":"2008","unstructured":"Joshi, R., Jan, S., Wu, Y. & MacMahon, S. Global inequalities in access to cardiovascular health care: Our greatest challenge. J. Am. Coll. Cardiol. 52(23), 1817\u20131825. https:\/\/doi.org\/10.1016\/j.jacc.2008.08.049 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"45344_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.026587","volume":"11","author":"PH Mullachery","year":"2022","unstructured":"Mullachery, P. H. et al. Inequalities by income in the prevalence of cardiovascular disease and its risk factors in the adult population of Catalonia. J. Am. Heart Assoc. 11(17), e026587. https:\/\/doi.org\/10.1161\/jaha.122.026587 (2022).","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"45344_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.007917","volume":"15","author":"Z Javed","year":"2022","unstructured":"Javed, Z. et al. Race, racism, and cardiovascular health: Applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease. Circ. Cardiovasc. Qual. Outcomes. 15(1), e007917. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.121.007917 (2022).","journal-title":"Circ. Cardiovasc. Qual. Outcomes."},{"issue":"2","key":"45344_CR34","volume":"4","author":"C Preethi","year":"2024","unstructured":"Preethi, C. & Ralf, W. Diabetes mellitus and heart disease. Metab. Target Organ Damage 4(2), 18 (2024).","journal-title":"Metab. Target Organ Damage"},{"issue":"3","key":"45344_CR35","volume":"4","author":"AF Yetunde","year":"2024","unstructured":"Yetunde, A. F. et al. Obesity and diabetes in heart disease in women. Metab. Target Organ Damage 4(3), 22 (2024).","journal-title":"Metab. Target Organ Damage"},{"issue":"1","key":"45344_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02601-0","volume":"22","author":"F Zibaeenejad","year":"2022","unstructured":"Zibaeenejad, F., Mohammadi, S. S., Sayadi, M., Safari, F. & Zibaeenezhad, M. J. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: A cohort-based cross-sectional study. BMC Cardiovasc. Disord. 22(1), 162. https:\/\/doi.org\/10.1186\/s12872-022-02601-0 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"issue":"1","key":"45344_CR37","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1180","volume":"18","author":"N Fahimfar","year":"2023","unstructured":"Fahimfar, N. et al. The trend of risk for cardiovascular diseases during the past decade in Iran, applying no-lab and lab-based prediction models. Glob. Heart 18(1), 3. https:\/\/doi.org\/10.5334\/gh.1180 (2023).","journal-title":"Glob. Heart"},{"issue":"22","key":"45344_CR38","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1161\/hc4601.099487","volume":"104","author":"S Yusuf","year":"2001","unstructured":"Yusuf, S., Reddy, S., \u00d4unpuu, S. & Anand, S. Global burden of cardiovascular diseases. Circulation 104(22), 2746\u20132753. https:\/\/doi.org\/10.1161\/hc4601.099487 (2001).","journal-title":"Circulation"},{"issue":"6","key":"45344_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002581","volume":"15","author":"P Geldsetzer","year":"2018","unstructured":"Geldsetzer, P. et al. Geographic and sociodemographic variation of cardiovascular disease risk in India: A cross-sectional study of 797,540 adults. PLoS Med. 15(6), e1002581. https:\/\/doi.org\/10.1371\/journal.pmed.1002581 (2018).","journal-title":"PLoS Med."},{"issue":"18","key":"45344_CR40","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/eurjpc\/zwac161","volume":"29","author":"MD Chobufo","year":"2022","unstructured":"Chobufo, M. D. et al. Temporal trends in atherosclerotic cardiovascular disease risk among U.S. adults. Analysis of the national health and nutrition examination survey, 1999-2018. Eur. J. Prev. Cardiol. 29(18), 2289\u20132300. https:\/\/doi.org\/10.1093\/eurjpc\/zwac161 (2022).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"45344_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jacl.2021.11.009","volume":"16","author":"GL Vega","year":"2022","unstructured":"Vega, G. L., Wang, J. & Grundy, S. M. Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease. J. Clin. Lipidol. 16(1), 66\u201374. https:\/\/doi.org\/10.1016\/j.jacl.2021.11.009 (2022).","journal-title":"J. Clin. Lipidol."},{"issue":"2","key":"45344_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ijcard.2014.07.101","volume":"176","author":"K Lee","year":"2014","unstructured":"Lee, K. 10-year risk for atherosclerotic cardiovascular disease and coronary heart disease among Korean adults: Findings from the Korean national health and nutrition examination survey 2009\u20132010. Int. J. Cardiol. 176(2), 418\u2013422. https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.101 (2014).","journal-title":"Int. J. Cardiol."},{"key":"45344_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1043894","volume":"13","author":"S Djalalinia","year":"2022","unstructured":"Djalalinia, S. et al. The levels of BMI and patterns of obesity and overweight during the COVID-19 pandemic: Experience from the Iran STEPs 2021 survey. Front. Endocrinol. 13, 1043894. https:\/\/doi.org\/10.3389\/fendo.2022.1043894 (2022).","journal-title":"Front. Endocrinol."},{"key":"45344_CR44","doi-asserted-by":"crossref","unstructured":"Mahsa Heidari-Foroozan NR, Mohammad-Reza Malekpour et al. Hypertension prevalence and cascade of care in Iran: Updates from the STEPs 2021 national and subnational survey PREPRINT (Version 1). (2024).","DOI":"10.21203\/rs.3.rs-3842876\/v1"},{"key":"45344_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00042","volume":"11","author":"S Djalalinia","year":"2020","unstructured":"Djalalinia, S. et al. Patterns of obesity and overweight in the Iranian population: Findings of STEPs 2016. Front. Endocrinol. 11, 42. https:\/\/doi.org\/10.3389\/fendo.2020.00042 (2020).","journal-title":"Front. Endocrinol."},{"issue":"10","key":"45344_CR46","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/jamainternmed.2019.2396","volume":"179","author":"P Kazemian","year":"2019","unstructured":"Kazemian, P., Shebl, F. M., McCann, N., Walensky, R. P. & Wexler, D. J. Evaluation of the cascade of diabetes care in the United States, 2005-2016. JAMA Intern. Med. 179(10), 1376\u20131385. https:\/\/doi.org\/10.1001\/jamainternmed.2019.2396 (2019).","journal-title":"JAMA Intern. Med."},{"issue":"23","key":"45344_CR47","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMsa2032271","volume":"384","author":"M Fang","year":"2021","unstructured":"Fang, M., Wang, D., Coresh, J. & Selvin, E. Trends in diabetes treatment and control in U.S. adults, 1999\u20132018. N. Engl. J. Med. 384(23), 2219\u20132228. https:\/\/doi.org\/10.1056\/NEJMsa2032271 (2021).","journal-title":"N. Engl. J. Med."},{"key":"45344_CR48","unstructured":"Turkey Hypertension Fact Sheet: WHO; 2017 [Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/hypertension\/tur_en.pdf?sfvrsn=a5c754a2_9&;download=true."},{"issue":"8","key":"45344_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255959","volume":"16","author":"J Jankovi\u0107","year":"2021","unstructured":"Jankovi\u0107, J., Mandi\u0107-Raj\u010devi\u0107, S., Davidovi\u0107, M. & Jankovi\u0107, S. Demographic and socioeconomic inequalities in ideal cardiovascular health: A systematic review and meta-analysis. PLoS ONE 16(8), e0255959. https:\/\/doi.org\/10.1371\/journal.pone.0255959 (2021).","journal-title":"PLoS ONE"},{"issue":"5","key":"45344_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006385","volume":"5","author":"A Afshin","year":"2015","unstructured":"Afshin, A. et al. The impact of dietary habits and metabolic risk factors on cardiovascular and diabetes mortality in countries of the Middle East and North Africa in 2010: A comparative risk assessment analysis. BMJ Open 5(5), e006385. https:\/\/doi.org\/10.1136\/bmjopen-2014-006385 (2015).","journal-title":"BMJ Open"},{"issue":"1","key":"45344_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1017\/s0007114511005393","volume":"108","author":"A Esteghamati","year":"2012","unstructured":"Esteghamati, A. et al. Patterns of fruit and vegetable consumption among Iranian adults: A SuRFNCD-2007 study. Br. J. Nutr. 108(1), 177\u2013181. https:\/\/doi.org\/10.1017\/s0007114511005393 (2012).","journal-title":"Br. J. Nutr."},{"issue":"12","key":"45344_CR52","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1097\/HJH.0000000000001836","volume":"36","author":"S Rezaei","year":"2018","unstructured":"Rezaei, S. et al. Salt intake among Iranian population: The first national report on salt intake in Iran. J. Hypertens. 36(12), 2380\u20132389 (2018).","journal-title":"J. Hypertens."},{"issue":"8","key":"45344_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/ircmj.57874","volume":"19","author":"A Zargaraan","year":"2017","unstructured":"Zargaraan, A., Dinarvand, R. & Hosseini, H. Nutritional traffic light labeling and taxation on unhealthy food products in Iran: Health policies to prevent non-communicable diseases. Iran. Red Crescent Med. J. 19(8), 1\u20132. https:\/\/doi.org\/10.5812\/ircmj.57874 (2017).","journal-title":"Iran. Red Crescent Med. J."},{"issue":"1","key":"45344_CR54","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1002\/hpm.2924","volume":"35","author":"S Edalati","year":"2020","unstructured":"Edalati, S., Omidvar, N., Haghighian Roudsari, A., Ghodsi, D. & Zargaraan, A. Development and implementation of nutrition labelling in Iran: A retrospective policy analysis. Int. J. Health Plann. Manag. 35(1), e28\u2013e44. https:\/\/doi.org\/10.1002\/hpm.2924 (2020).","journal-title":"Int. J. Health Plann. Manag."},{"issue":"23","key":"45344_CR55","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1161\/cir.0000000000001031","volume":"144","author":"AH Lichtenstein","year":"2021","unstructured":"Lichtenstein, A. H. et al. 2021 Dietary guidance to improve cardiovascular health: A scientific statement from the American heart association. Circulation 144(23), e472\u2013e487. https:\/\/doi.org\/10.1161\/cir.0000000000001031 (2021).","journal-title":"Circulation"},{"issue":"19","key":"45344_CR56","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017458","volume":"9","author":"B Gaye","year":"2020","unstructured":"Gaye, B. et al. Association of changes in cardiovascular health metrics and risk of subsequent cardiovascular disease and mortality. J. Am. Heart Assoc. 9(19), e017458. https:\/\/doi.org\/10.1161\/JAHA.120.017458 (2020).","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"45344_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79322-x","volume":"11","author":"F Rahmani","year":"2021","unstructured":"Rahmani, F. et al. National trends in cardiovascular health metrics among Iranian adults using results of three cross-sectional STEPwise approaches to surveillance surveys. Sci. Rep. 11(1), 58. https:\/\/doi.org\/10.1038\/s41598-020-79322-x (2021).","journal-title":"Sci. Rep."},{"issue":"8","key":"45344_CR58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/CIRCOUTCOMES.122.009787","volume":"16","author":"AM Navar","year":"2023","unstructured":"Navar, A. M. et al. Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: A retrospective cohort study of 322\u2005153 patients. Circ. Cardiovasc. Qual. Outcomes 16(8), 533\u2013543. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.122.009787 (2023).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"14","key":"45344_CR59","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/eurjpc\/zwac103","volume":"29","author":"MD Chobufo","year":"2022","unstructured":"Chobufo, M. D. et al. Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: From the national health and nutrition examination survey 2017-2020. Eur. J. Prev. Cardiol. 29(14), 1830\u20131838. https:\/\/doi.org\/10.1093\/eurjpc\/zwac103 (2022).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"45344_CR60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.pcad.2022.08.007","volume":"75","author":"K Gupta","year":"2022","unstructured":"Gupta, K. et al. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA\/ACC\/ multi-society guideline recommendations: From National health and nutrition examination survey. Prog. Cardiovasc. Dis. 75, 78\u201382. https:\/\/doi.org\/10.1016\/j.pcad.2022.08.007 (2022).","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"1","key":"45344_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23364-9","volume":"8","author":"S Asgari","year":"2018","unstructured":"Asgari, S. et al. The burden of statin therapy based on ACC\/AHA and NCEP ATP-III guidelines: An Iranian survey of non-communicable diseases risk factors. Sci. Rep. 8(1), 4928. https:\/\/doi.org\/10.1038\/s41598-018-23364-9 (2018).","journal-title":"Sci. Rep."},{"issue":"8","key":"45344_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000320","volume":"7","author":"S Capewell","year":"2010","unstructured":"Capewell, S. & Graham, H. Will cardiovascular disease prevention widen health inequalities?. PLoS. Med. 7(8), e1000320. https:\/\/doi.org\/10.1371\/journal.pmed.1000320 (2010).","journal-title":"PLoS. Med."},{"issue":"2","key":"45344_CR63","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s40200-020-00673-3","volume":"19","author":"S Azadnajafabad","year":"2020","unstructured":"Azadnajafabad, S. et al. Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: A focus on prevention strategies and treatment coverage. J. Diabetes Metab. Disord. 19(2), 1453\u20131463. https:\/\/doi.org\/10.1007\/s40200-020-00673-3 (2020).","journal-title":"J. Diabetes Metab. Disord."},{"issue":"1","key":"45344_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/mbp.0000000000000612","volume":"28","author":"M Keykhaei","year":"2023","unstructured":"Keykhaei, M. et al. Population attributable fraction estimates of cardiovascular diseases in different blood pressure levels in a large-scale cross-sectional study: A focus on prevention strategies and treatment coverage. Blood Press. Monit. 28(1), 1\u201310. https:\/\/doi.org\/10.1097\/mbp.0000000000000612 (2023).","journal-title":"Blood Press. Monit."},{"issue":"2","key":"45344_CR65","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s40200-020-00663-5","volume":"19","author":"E Mohammadi","year":"2020","unstructured":"Mohammadi, E. et al. Estimating the attributable risk of vascular disorders in different ranges of fasting plasma glucose and assessing the effectiveness of anti-diabetes agents on risk reduction; questioning the current diagnostic criteria. J. Diabetes Metab. Disord. 19(2), 1423\u20131430. https:\/\/doi.org\/10.1007\/s40200-020-00663-5 (2020).","journal-title":"J. Diabetes Metab. Disord."},{"issue":"1","key":"45344_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13615-w","volume":"22","author":"M Yousefi","year":"2022","unstructured":"Yousefi, M. et al. Prevention and control of non-communicable diseases in Iran: The case for investment. BMC Public Health 22(1), 1248. https:\/\/doi.org\/10.1186\/s12889-022-13615-w (2022).","journal-title":"BMC Public Health"},{"key":"45344_CR67","doi-asserted-by":"publisher","DOI":"10.4103\/jrms.jrms_851_23","volume":"29","author":"N Sarrafzadegan","year":"2024","unstructured":"Sarrafzadegan, N. et al. Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome. J. Res. Med. Sci. 29, 32. https:\/\/doi.org\/10.4103\/jrms.jrms_851_23 (2024).","journal-title":"J. Res. Med. Sci."},{"issue":"1","key":"45344_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21168-3","volume":"25","author":"S Derakhshan","year":"2025","unstructured":"Derakhshan, S. et al. Evaluation of the effectiveness of the Iran-package of essential non-communicable disease (IraPEN) program in reducing cardiovascular disease risk in pilot areas. BMC Public Health 25(1), 429. https:\/\/doi.org\/10.1186\/s12889-024-21168-3 (2025).","journal-title":"BMC Public Health"},{"issue":"10199","key":"45344_CR69","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","volume":"394","author":"G Roshandel","year":"2019","unstructured":"Roshandel, G. et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): A pragmatic, cluster-randomised trial. Lancet 394(10199), 672\u2013683. https:\/\/doi.org\/10.1016\/S0140-6736(19)31791-X (2019).","journal-title":"Lancet"},{"key":"45344_CR70","first-page":"1","volume-title":"Handbook of Public Health Nutrition: International, National, and Regional Perspectives","author":"M Babashahi","year":"2025","unstructured":"Babashahi, M. & Setoude, N. Food Traffic Light Labeling Policy and Implications for Public Health Nutrition in Iran. In Handbook of Public Health Nutrition: International, National, and Regional Perspectives (eds Preedy, V. R. & Patel, V. B.) 1\u201315 (Springer Nature Switzerland, 2025)."},{"issue":"22","key":"45344_CR71","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","volume":"86","author":"Collaborators GBoCDaR","year":"2025","unstructured":"Collaborators GBoCDaR. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. JACC 86(22), 2167\u20132243. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.015 (2025).","journal-title":"JACC"},{"issue":"2","key":"45344_CR72","doi-asserted-by":"publisher","DOI":"10.21542\/gcsp.2018.13","volume":"2018","author":"E Vartiainen","year":"2018","unstructured":"Vartiainen, E. The North Karelia project: Cardiovascular disease prevention in Finland. Glob. Cardiol. Sci. Pract. 2018(2), 13. https:\/\/doi.org\/10.21542\/gcsp.2018.13 (2018).","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"45344_CR73","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV22047","author":"A Hirata","year":"2025","unstructured":"Hirata, A. & Uchida, T. The Specific health checkups and specific health guidance program: A strategy for the prevention of cardiovascular disease in Japan. J. Atheroscler. Thromb. https:\/\/doi.org\/10.5551\/jat.RV22047 (2025).","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"45344_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101676","volume":"4","author":"M Dalakoti","year":"2025","unstructured":"Dalakoti, M. et al. Primary prevention of cardiovascular disease in Asia: Opportunities and solutions: A narrative review. JACC Adv. 4(4), 101676. https:\/\/doi.org\/10.1016\/j.jacadv.2025.101676 (2025).","journal-title":"JACC Adv."},{"issue":"1","key":"45344_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-017-0288-4","volume":"16","author":"N Peykari","year":"2017","unstructured":"Peykari, N. et al. National action plan for non-communicable diseases prevention and control in Iran; A response to emerging epidemic. J. Diabetes Metab. Disord. 16(1), 3. https:\/\/doi.org\/10.1186\/s40200-017-0288-4 (2017).","journal-title":"J. Diabetes Metab. Disord."},{"issue":"14","key":"45344_CR76","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jama.2014.2632","volume":"311","author":"M Kavousi","year":"2014","unstructured":"Kavousi, M. et al. Comparison of application of the ACC\/AHA guidelines, adult treatment panel III guidelines, and European Society of cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA 311(14), 1416\u20131423. https:\/\/doi.org\/10.1001\/jama.2014.2632 (2014).","journal-title":"JAMA"},{"issue":"15","key":"45344_CR77","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jacc.2023.07.018","volume":"82","author":"JR Medina-Inojosa","year":"2023","unstructured":"Medina-Inojosa, J. R. et al. Performance of the ACC\/AHA pooled cohort cardiovascular risk equations in clinical practice. J. Am. Coll. Cardiol. 82(15), 1499\u20131508. https:\/\/doi.org\/10.1016\/j.jacc.2023.07.018 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"45344_CR78","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2023.08.024","volume":"82","author":"DM Lloyd-Jones","year":"2023","unstructured":"Lloyd-Jones, D. M. The pooled cohort equations and the Test of Time\u2217. J. Am. Coll. Cardiol. 82(15), 1509\u20131511. https:\/\/doi.org\/10.1016\/j.jacc.2023.08.024 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"45344_CR79","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/eurheartj\/ehw301","volume":"38","author":"AP DeFilippis","year":"2017","unstructured":"DeFilippis, A. P. et al. Risk score overestimation: The impact of individual cardiovascular risk factors and preventive therapies on the performance of the American heart association-American college of cardiology-atherosclerotic cardiovascular disease risk score in a modern multi-ethnic cohort. Eur. Heart J. 38(8), 598\u2013608. https:\/\/doi.org\/10.1093\/eurheartj\/ehw301 (2017).","journal-title":"Eur. Heart J."},{"issue":"5","key":"45344_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2024.103025","volume":"18","author":"X-J Dong","year":"2024","unstructured":"Dong, X.-J., Zhang, X.-Q., Wang, B.-B., Hou, F.-F. & Jiao, Y. The burden of cardiovascular disease attributable to high fasting plasma glucose: Findings from the Global Burden of Disease Study 2019. Diabetes Metab. Syndr. 18(5), 103025. https:\/\/doi.org\/10.1016\/j.dsx.2024.103025 (2024).","journal-title":"Diabetes Metab. Syndr."},{"issue":"9","key":"45344_CR81","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1111\/dom.16529","volume":"27","author":"X Dong","year":"2025","unstructured":"Dong, X. et al. Worldwide burden of metabolic risk-related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Diabetes Obes. Metab. 27(9), 4859\u20134882. https:\/\/doi.org\/10.1111\/dom.16529 (2025).","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"45344_CR82","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/ehjqcco\/qcaa062","volume":"7","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic. Eur. Heart J. Qual. Care Clin. Outcomes. 7(3), 238\u2013246. https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa062 (2021).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes."},{"issue":"7","key":"45344_CR83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/ehjqcco\/qcad051","volume":"9","author":"Y Khan","year":"2023","unstructured":"Khan, Y. et al. The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: A systematic review. Eur. Heart J. Qual. Care Clin. Outcomes. 9(7), 647\u2013661. https:\/\/doi.org\/10.1093\/ehjqcco\/qcad051 (2023).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes."}],"updated-by":[{"DOI":"10.1038\/s41598-026-50915-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45344-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:48:32Z","timestamp":1777466912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45344-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45344"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45344-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-50915-2","URL":"https:\/\/doi.org\/10.1038\/s41598-026-50915-2","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Research Ethics Committees of the National Institute of Health Research of the I.R. Iran and Tehran University of Medical Sciences (IR.TUMS.NIHR.REC.1398.006). Participants gave informed consent through in-person discussion and were given the written documentation describing the purpose of the study and the included procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"10825"}}